The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Lipodystrophies: Genetic and Acquired Body Fat Disorders
Open accessAbstract
Context: Lipodystrophies are heterogeneous, genetic or acquired disorders characterized by selective loss of body fat and predisposition to insulin resistance. The extent of fat loss determines the severity of associated metabolic complications such as diabetes mellitus, hypertriglyceridemia, and hepatic steatosis. Evidence Acquisition and Synthesis: Both original and review articles were found via PubMed search reporting on clinical features and management of various types of lipodystrophies and were integrated with the author's knowledge of the field. Conclusion: The autosomal recessive congenital generalized lipodystrophy and autosomal dominant familial partial lipodystrophy (FPL) are the two most common types of genetic lipodystrophies. Mutations in AGPAT2, BSCL2, CAV1, and PTRF have been reported in congenital generalized lipodystrophy and in LMNA, PPARG, AKT2, and PLIN1 in FPL. CIDEC is the disease gene for autosomal recessive, FPL and LMNA and ZMPSTE24 for autosomal recessive, mandibuloacral dysplasia-associated lipodystrophy. Recently, an autosomal recessive autoinflammatory lipodystrophy syndrome was reported to be due to PSMB8 mutation. Molecular genetic bases of many rare forms of genetic lipodystrophies remain to be elucidated. The most prevalent subtype of acquired lipodystrophy currently occurs with prolonged duration of protease inhibitor-containing, highly-active antiretroviral therapy in HIV-infected patients. The acquired generalized and partial lipodystrophies are mainly autoimmune in origin and display complement abnormalities. Localized lipodystrophies occur due to drug or vaccine injections, pressure, panniculitis, and other unknown reasons. The current management includes cosmetic surgery and early identification and treatment of metabolic and other complications with diet, exercise, hypoglycemic drugs, and lipid-lowering agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D. J., & Cooper, D. A. (1998) · AIDS · doi:10.1097/00002030-199807000-00003 · Cited by 2,370
Leptin-Replacement Therapy for Lipodystrophy
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247
Self-citationCardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
Grinspoon, S., & Carr, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041811 · Cited by 1,070
Acquired and Inherited Lipodystrophies
Garg, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra025261 · Cited by 941
Self-citationPPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13
Magré, J., Delépine, M., Khallouf, E., Gedde-Dahl, T., Van Maldergem, L., Sobel, E., Papp, J., Meier, M., Mégarbané, A., BSCL Working Group, et al. (2001) · Nature Genetics · doi:10.1038/ng585 · Cited by 756
Phenotype and Course of Hutchinson–Gilford Progeria Syndrome
Merideth, M. A., Gordon, L. B., Clauss, S., Sachdev, V., Smith, A. C. M., Perry, M. B., Brewer, C. C., Zalewski, C., Kim, H. J., Solomon, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706898 · Cited by 743
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
Shackleton, S., Lloyd, D. J., Jackson, S. N. J., Evans, R., Niermeijer, M. F., Singh, B. M., Schmidt, H., Brabant, G., Kumar, S., Durrington, P. N., et al. (2000) · Nature Genetics · doi:10.1038/72807 · Cited by 704
Cao, H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.1.109 · Cited by 662
Carr, A., Miller, J., Law, M., & Cooper, D. A. (2000) · AIDS · doi:10.1097/00002030-200002180-00001 · Cited by 630
Szymanski, K. M., Binns, D., Bartz, R., Grishin, N. V., Li, W.-P., Agarwal, A. K., Garg, A., Anderson, R. G. W., & Goodman, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704154104 · Cited by 628
Self-citationThe Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor Therapy
Murata, H., Hruz, P. W., & Mueckler, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000228200 · Cited by 586
A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2
George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C., Soos, M. A., Murgatroyd, P. R., Williams, R. M., Acerini, C. L., et al. (2004) · Science · doi:10.1126/science.1096706 · Cited by 559
Mandibuloacral Dysplasia Is Caused by a Mutation in LMNA-Encoding Lamin A/C
Novelli, G., Muchir, A., Sangiuolo, F., Helbling-Leclerc, A., D’Apice, M. R., Massart, C., Capon, F., Sbraccia, P., Federici, M., Lauro, R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341908 · Cited by 553
AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34
Agarwal, A. K., Arioglu, E., de Almeida, S., Akkoc, N., Taylor, S. I., Bowcock, A. M., Barnes, R. I., & Garg, A. (2002) · Nature Genetics · doi:10.1038/ng880 · Cited by 523
Self-citationFld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast
Fei, W., Shui, G., Gaeta, B., Du, X., Kuerschner, L., Li, P., Brown, A. J., Wenk, M. R., Parton, R. G., & Yang, H. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711136 · Cited by 469
Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis
Takeuchi, K., & Reue, K. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90958.2008 · Cited by 463
Bastard, J.-P., Caron, M., Vidal, H., Jan, V., Auclair, M., Vigouroux, C., Luboinski, J., Laville, M., Maachi, M., Girard, P.-M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08094-7 · Cited by 405
Long-Term Outcome and Risk Stratification in Dilated Cardiolaminopathies
Pasotti, M., Klersy, C., Pilotto, A., Marziliano, N., Rapezzi, C., Serio, A., Mannarino, S., Gambarin, F., Favalli, V., Grasso, M., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.06.044 · Cited by 404
Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia
Agarwal, A. K. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg213 · Cited by 401
Hayashi, Y. K., Matsuda, C., Ogawa, M., Goto, K., Tominaga, K., Mitsuhashi, S., Park, Y.-E., Nonaka, I., Hino-Fukuyo, N., Haginoya, K., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38660 · Cited by 394
Nishino, N., Tamori, Y., Tateya, S., Kawaguchi, T., Shibakusa, T., Mizunoya, W., Inoue, K., Kitazawa, R., Kitazawa, S., Matsuki, Y., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34090 · Cited by 392
Kim, C. A., Delépine, M., Boutet, E., El Mourabit, H., Le Lay, S., Meier, M., Nemani, M., Bridel, E., Leite, C. C., Bertola, D. R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1328 · Cited by 391
AN UNDIAGNOSED ENDOCRINOMETABOLIC SYNDROME: REPORT OF 2 CASES*
BERARDINELLI, W. (1954) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-14-2-193 · Cited by 385
Garg, A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00414-3 · Cited by 372
Self-citationPostreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis
Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L., Jackson, S., Vottero, A., Kanabar, D., Charlton-Menys, V., Durrington, P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37432 · Cited by 344
Agarwal, A. K., Xing, C., DeMartino, G. N., Mizrachi, D., Hernandez, M. D., Sousa, A. B., Martínez de Villarreal, L., dos Santos, H. G., & Garg, A. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.10.031 · Cited by 335
Self-citationPerilipin Deficiency and Autosomal Dominant Partial Lipodystrophy
Gandotra, S., Le Dour, C., Bottomley, W., Cervera, P., Giral, P., Reznik, Y., Charpentier, G., Auclair, M., Delépine, M., Barroso, I., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007487 · Cited by 310
Rubio‐Cabezas, O., Puri, V., Murano, I., Saudek, V., Semple, R. K., Dash, S., Hyden, C. S. S., Bottomley, W., Vigouroux, C., Magré, J., et al. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900037 · Cited by 298
Self-citationMisra, A., Peethambaram, A., & Garg, A. (2004) · Medicine · doi:10.1097/01.md.0000111061.69212.59 · Cited by 285
Self-citationSpeckman, R. A., Garg, A., Du, F., Bennett, L., Veile, R., Arioglu, E., Taylor, S. I., Lovett, M., & Bowcock, A. M. (2000) · The American Journal of Human Genetics · doi:10.1086/302836 · Cited by 273
Self-citationAgarwal, A. K., & Garg, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8290 · Cited by 268
Self-citationPPARG F388L, a Transactivation-Deficient Mutant, in Familial Partial Lipodystrophy
Hegele, R. A., Cao, H., Frankowski, C., Mathews, S. T., & Leff, T. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3586 · Cited by 264
Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy
Van Maldergem, L., Magré, J., Khallouf, T. E., Gedde-Dahl, T., Delépine, M., Trygstad, O., Seemanova, E., Stephenson, T., Albott, C. S., Bonnici, F., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.10.722 · Cited by 250
Phenotypic and Genetic Heterogeneity in Congenital Generalized Lipodystrophy
Agarwal, A. K., Simha, V., Oral, E. A., Moran, S. A., Gorden, P., O’Rahilly, S., Zaidi, Z., Gurakan, F., Arslanian, S. A., Klar, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030855 · Cited by 246
Self-citationMisra, A., & Garg, A. (2003) · Medicine · doi:10.1097/00005792-200303000-00007 · Cited by 241
Self-citationLipodystrophy and Gigantism with Associated Endocrine Manifestations: A New Diencephalic Syndrome?
SEIP, M. (1959) · Acta Paediatrica · doi:10.1111/j.1651-2227.1959.tb16421.x · Cited by 239
Rajab, A., Straub, V., McCann, L. J., Seelow, D., Varon, R., Barresi, R., Schulze, A., Lucke, B., Lützkendorf, S., Karbasiyan, M., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000874 · Cited by 236
Lipodystrophy in Human Immunodeficiency Virus-Infected Patients
Chen, D., Misra, A., & Garg, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020794 · Cited by 229
Self-citationCaron, M., Auclair, M., Donadille, B., Béréziat, V, Guerci, B., Laville, M., Narbonne, H., Bodemer, C., Lascols, O., Capeau, J., et al. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402197 · Cited by 226 · cited 1×
“Adipocyte loss in patients with LMNA mutations may be due to disruption of nuclear envelope functionand integrity resulting in premature cell death (63).”
BackgroundLee, H., Hanes, J., & Johnson, K. A. (2003) · Biochemistry · doi:10.1021/bi035596s · Cited by 219
Torrelo, A., Patel, S., Colmenero, I., Gurbindo, D., Lendínez, F., Hernández, A., López-Robledillo, J. C., Dadban, A., Requena, L., & Paller, A. S. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.04.046 · Cited by 215
HIV Protease Inhibitor-Related Lipodystrophy Syndrome
Carr, A. (2000) · Clinical Infectious Diseases · doi:10.1086/313854 · Cited by 210
Hegele, R. A., Cao, H., Liu, D. M., Costain, G. A., Charlton-Menys, V., Rodger, N. W., & Durrington, P. N. (2006) · The American Journal of Human Genetics · doi:10.1086/505885 · Cited by 207
The Human Lipodystrophy Gene BSCL2/Seipin May Be Essential for Normal Adipocyte Differentiation
Payne, V. A., Grimsey, N., Tuthill, A., Virtue, S., Gray, S. L., Dalla Nora, E., Semple, R. K., O'Rahilly, S., & Rochford, J. J. (2008) · Diabetes · doi:10.2337/db08-0184 · Cited by 199
Garg, A., Peshock, R. M., & Fleckenstein, J. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5383 · Cited by 197
Self-citationSEIP, M. (1959) · Acta Paediatrica · doi:10.1111/j.1651-2227.1959.tb17558.x · Cited by 195
A Gene for Congenital Generalized Lipodystrophy Maps to Human Chromosome 9q34
Garg, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3390 · Cited by 192
Self-citationGarg, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1776 · Cited by 189
Self-citationLipodystrophies: disorders of adipose tissue biology.
Garg, A., & Agarwal, A. K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.12.014 · Cited by 184
Self-citationSimha, V., & Garg, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030835 · Cited by 180
Self-citationFamilial Lipoatrophic Diabetes with Dominant Transmission<subtitle>A NEW SYNDROME1</subtitle>
(1974) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067376 · Cited by 169
Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways
Agarwal, A. K., & Garg, A. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00078-x · Cited by 165
Self-citationLocalization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21–22
Peters, J. M., Barnes, R., Bennett, L., Gitomer, W. M., Bowcock, A. M., & Garg, A. (1998) · Nature Genetics · doi:10.1038/ng0398-292 · Cited by 158
Self-citationLIPODYSTROPHIES: REPORT OF SEVEN CASES
Ziegler, L. H. (1928) · Brain · doi:10.1093/brain/51.2.147 · Cited by 158
Köbberling, J., & Dunnigan, M. G. (1986) · Journal of Medical Genetics · doi:10.1136/jmg.23.2.120 · Cited by 152
Genetic disorders of adipose tissue development, differentiation, and death.
Agarwal, A. K., & Garg, A. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115715 · Cited by 150
Lipodystrophies: rare disorders causing metabolic syndrome
Garg, A., & Misra, A. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.003 · Cited by 147
Self-citationGarg, A., Speckman, R. A., & Bowcock, A. M. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01070-7 · Cited by 146
Self-citationGarg, A., Vinaitheerthan, M., Weatherall, P. T., & Bowcock, A. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7121 · Cited by 136
Self-citationSimha, V., Agarwal, A. K., Oral, E. A., Fryns, J., & Garg, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021575 · Cited by 136
Self-citationShastry, S., Delgado, M., Dirik, E., Turkmen, M., Agarwal, A. K., & Garg, A. (2010) · American Journal of Medical Genetics. Part A · doi:10.1002/ajmg.a.33578 · Cited by 134
Self-citationAtypical Progeroid Syndrome due to Heterozygous Missense LMNA Mutations
Garg, A., Subramanyam, L., Agarwal, A. K., Simha, V., Levine, B. D., D’Apice, M. R., Novelli, G., & Crow, Y. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0472 · Cited by 134
Self-citationLipodystrophy: lessons in lipid and energy metabolism
Simha, V., & Garg, A. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000217898.52197.18 · Cited by 129
Self-citationComplement-mediated adipocyte lysis by nephritic factor sera.
Mathieson, P. W., Würzner, R., Oliveria, D. B., Lachmann, P. J., & Peters, D. K. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.6.1827 · Cited by 128
Rivett, A. J., & Hearn, A. R. (2004) · Current Protein and Peptide Science · doi:10.2174/1389203043379774 · Cited by 127
Simha, V., Szczepaniak, L. S., Wagner, A. J., DePaoli, A. M., & Garg, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.30 · Cited by 121
Self-citationPark, J. Y., Javor, E. D., Cochran, E. K., DePaoli, A. M., & Görden, P. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.010 · Cited by 104
Falutz, J., Mamputu, J., Potvin, D., Moyle, G. J., Soulban, G., Loughrey, H. C., Marsolais, C., Turner, R. R., & Grinspoon, S. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0490 · Cited by 101
Garg, A., Hernandez, M. D., Sousa, A. B., Subramanyam, L., Villarreal, L., dos Santos, H. G., & Barboza, O. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0488 · Cited by 98
Self-citationPardini, V. C., Victoria, I. M. N., Rocha, S. M. V., Andrade, D. G., Rocha, A. M., Pieroni, F. B., Milagres, G., Purisch, S., & Velho, G. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4567 · Cited by 96
Triglyceride containing lipid droplets and lipid droplet-associated proteins
Olofsson, S., Boström, P., Andersson, L. K., Rutberg, M., Levin, M. C., Perman, J., & Borén, J. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32830dd09b · Cited by 93
Complement Abnormalities in Acquired Lipodystrophy Revisited
Savage, D. B., Semple, R. K., Clatworthy, M. R., Lyons, P., Morgan, B. P., Cochran, E. K., Görden, P., Raymond‐Barker, P., Murgatroyd, P. R., Adams, C., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1703 · Cited by 87
SINGULAR CASE OF ABSENCE OF ADIPOSE MATTER IN THE UPPER HALF OF THE BODY
Mitchell, S. W. (1885) · The American Journal of the Medical Sciences · doi:10.1097/00000441-188507000-00006 · Cited by 85
Prevalence of Mutations in AGPAT2 Among Human Lipodystrophies
Magré, J., Délepine, M., Maldergem, L. V., Robert, J., Maassen, J. A., Meier, M., Panz, V. R., Kim, C. A., Tubiana‐Rufi, N., Czernichow, P., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1573 · Cited by 84
Alshali, K. Z., Cao, H., Knoers, N. V. A. M., Hermus, A. R., Tack, C. J., & Hegele, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0280 · Cited by 77
Familial Partial Lipodystrophy: A Monogenic Form of the Insulin Resistance Syndrome
Hegele, R. A. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3092 · Cited by 75
Shastry, S., Simha, V., Godbole, K., Sbraccia, P., Melançon, S. B., Yajnik, C. S., Novelli, G., Kroiß, M., & Garg, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0419 · Cited by 74
Self-citationAgarwal, A. K., Zhou, X. J., Hall, R. K., Nicholls, K., Bankier, A., Esch, H. V., Fryns, J., & Garg, A. (2006) · Journal of Investigative Medicine · doi:10.2310/6650.2006.05068 · Cited by 73
Self-citationMitochondrial DNA mutations in multiple symmetric lipomatosis
Klopstock, T., Naumann, M. K., Seibel, P., Shalke, B., Reiners, K., & Reichmann, H. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6111-8_42 · Cited by 70
Mitochondrial DNA mutations in multiple symmetric lipomatosis
Klopstock, T., Naumann, M. K., Seibel, P., Shalke, B., Reiners, K., & Reichmann, H. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006877012241 · Cited by 64
Caveolin-1: A New Locus for Human Lipodystrophy
Garg, A., & Agarwal, A. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0426 · Cited by 59
Self-citationSubramanyam, L., Simha, V., & Garg, A. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01350.x · Cited by 57
Self-citationEarly onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24
Ahmad, Z., Zackai, E. H., Medne, L., & Garg, A. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33664 · Cited by 56
Self-citationAgarwal, A. K., & Garg, A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m004762 · Cited by 54
Self-citationHIV-protease inhibitors block the enzymatic activity of purified Ste24p
Hudon, S. E., Coffinier, C., Michaelis, S., Fong, L. G., Young, S. G., & Hrycyna, C. A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.033 · Cited by 51
Simha, V., Agarwal, A. K., Aronin, P. A., Iannaccone, S. T., & Garg, A. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32457 · Cited by 48
Self-citationBody fat distribution and metabolic variables in patients with neonatal progeroid syndrome
O'Neill, B., Simha, V., Kotha, V., & Garg, A. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31840 · Cited by 40
Self-citationSevere Insulin Resistance and Diabetes Mellitus in Mandibuloacral Dysplasia
Freidenberg, G. R. (1992) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1992.02160130095028 · Cited by 37
Fatty Acid Metabolism in Patients with PPARγ Mutations
Tan, G. D., Savage, D. B., Fielding, B. A., Collins, J. M., Hodson, L., Humphreys, S. M., O’Rahilly, S., Chatterjee, K., Frayn, K. N., & Karpe, F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2356 · Cited by 35
Simha, V., Rao, S., & Garg, A. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00978.x · Cited by 33
Self-citationA low birthweight syndrome, ? Rieger syndrome.
Sensenbrenner, J. A., Hussels, I. E., & Ls, L. (1975) · PubMed · Cited by 22
Cited by
What we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373
Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications
Stefan, N., Häring, H.-U., Hu, F. B., & Schulze, M. B. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70062-7 · Cited by 857
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
Kahn, C. R., Wang, G., & Lee, K. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129187 · Cited by 661
Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans
Stefan, N., Schick, F., & Häring, H.-U. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.008 · Cited by 575
Contribution of adipogenesis to healthy adipose tissue expansion in obesity
Vishvanath, L., & Gupta, R. K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129191 · Cited by 558
Metadata
- Authors
- Garg, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-11-01
- Volume
- 96
- Issue
- 11
- Pages
- 3313-3325
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2009330135
- Cited by
- 557
- References
- 93
- FWCI
- 23.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.